51 Recruiting Studies Using Bendamustine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Bendamustine
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Lymphoma
View Study & Checklist ➔A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Liver Lymphoma
View Study & Checklist ➔Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Lymphoma
View Study & Checklist ➔Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
Lymphoma
View Study & Checklist ➔A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
📍 Research Site — Chandler, Arizona
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
📍 Boston Medical Center — Boston, Massachusetts
AL Amyloidosis
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
📍 Local Institution - 0152 — Birmingham, Alabama
Lymphoma, Follicular
View Study & Checklist ➔FT819 in Subjects With B-cell Malignancies
📍 University of Alabama at Birmingham — Birmingham, Alabama
Lymphoma, B-Cell
View Study & Checklist ➔Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Grade 1 Follicular Lymphoma
View Study & Checklist ➔Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
📍 Southern Cancer Center, P.C. — Daphne, Alabama
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
📍 Ohio State University Medical Center — Columbus, Ohio
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
View Study & Checklist ➔Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Hodgkin Lymphoma, Adult
View Study & Checklist ➔Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage I Chronic Lymphocytic Leukemia
View Study & Checklist ➔Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
📍 UCSF Fresno /ID# 264712 — Fresno, California
Follicular Lymphoma (FL)
View Study & Checklist ➔A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
📍 Chao Family Comprehensive Cancer Center — Orange, California
Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
View Study & Checklist ➔Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Hairy Cell Leukemia
View Study & Checklist ➔A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
📍 California Research Institute — Los Angeles, California
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
📍 Highlands Oncology Group ( Site 5205) — Springdale, Arkansas
Chronic Lymphocytic Leukemia
View Study & Checklist ➔A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
📍 Augusta University — Augusta, Georgia
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
CCND1 Positive
View Study & Checklist ➔Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
Lymphoma
View Study & Checklist ➔Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
📍 Tom Baker Cancer Centre — Calgary, Alberta
Waldenstrom Macroglobulinemia
View Study & Checklist ➔Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
📍 City of Hope Comprehensive Cancer Center — Duarte, California
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
View Study & Checklist ➔Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Hodgkin Lymphoma
View Study & Checklist ➔A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
📍 Northwestern University — Chicago, Illinois
Follicular Lymphoma
View Study & Checklist ➔A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL
📍 Research Site — Tucson, Arizona
Lymphoma, Mantle Cell
View Study & Checklist ➔Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
📍 City of Hope National Medical Center — Duarte, California
Classical Hodgkin Lymphoma
View Study & Checklist ➔Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Mantle Cell Lymphoma
View Study & Checklist ➔Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Metastatic Malignant Solid Neoplasm
View Study & Checklist ➔B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
📍 Mayo Clinic in Florida — Jacksonville, Florida
B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Platinum-Resistant Fallopian Tube Carcinoma
View Study & Checklist ➔Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Recurrent Follicular Lymphoma
View Study & Checklist ➔A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
📍 St Bernards Medical Center — Jonesboro, Arkansas
CLL
View Study & Checklist ➔Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
📍 University of Kansas Medical Center — Kansas City, Kansas
Primary Progressive Multiple Sclerosis
View Study & Checklist ➔A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
📍 Alta Bates Summit Medical Center — Berkeley, California
Lymphoma
View Study & Checklist ➔Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
📍 Colorado Blood Cancer Institute (CBCI) — Denver, Colorado
Waldenstrom Macroglobulinemia
View Study & Checklist ➔CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
📍 Lineberger Comprehensive Cancer Center at University of North Carolina — Chapel Hill, North Carolina
Peripheral T Cell Lymphoma
View Study & Checklist ➔A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
📍 Duke Cancer Center Clinic 1B/C Onc/Heme ( Site 1307) — Durham, North Carolina
Follicular Lymphoma
View Study & Checklist ➔FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Advanced Solid Tumor
View Study & Checklist ➔A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
📍 University of Arizona Cancer Center — Tucson, Arizona
Follicular Lymphoma (FL)
View Study & Checklist ➔Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Classical Hodgkin Lymphoma
View Study & Checklist ➔A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
📍 Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) — Glendale, Arizona
DLBCL
View Study & Checklist ➔CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Recurrent B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Recurrent T-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔DALY II USA/ MB-CART2019.1 for DLBCL
📍 University of Alabama at Birmingham — Birmingham, Alabama
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
📍 Local Institution - 0225 — Birmingham, Alabama
Follicular Lymphoma
View Study & Checklist ➔BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
📍 Mayo Clinic Arizona — Phoenix, Arizona
Mantle Cell Lymphoma
View Study & Checklist ➔Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Hematopoietic and Lymphoid System Neoplasm
View Study & Checklist ➔A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
📍 Wallace Rheumatic Center — Beverly Hills, California
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)
View Study & Checklist ➔Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
📍 Lineberger Comprehensive Cancer Center at University of North Carolina — Chapel Hill, North Carolina
Mantle Cell Lymphoma
View Study & Checklist ➔